LAURA HORAN: Open Payments
NPI 1962438986 · KING OF PRUSSIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 23 payments from 11 companies in 2025. Trend: 2023 $90 · 2024 $260 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 6 | $155 |
| Boston Scientific Corporation | 1 | $113 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $73 |
| Sumitomo Pharma America, Inc. | 3 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
| Astellas Pharma US Inc | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $18 |
| Evofem Biosciences, Inc. | 1 | $17 |
| Hologic Sales and Service, LLC | 1 | $16 |
Products named: ZURZUVAE, Advantage System, MYFEMBREE, JOURNAVX, Veozah, Qelbree, LILETTA, Phexxi.
Industry payments across PA — which companies pay providers there.
